Target intelligence / Profile preview

Golgin A6 family like 24 (GOLGA6L24)

Target
GOLGA6L24
Molecular classification
Other (pseudogene)
01

Overview

Golgin A6 family like 24 (GOLGA6L24) is annotated as a member of the golgin A6 protein family; however, it is primarily classified as a *pseudogene* (sometimes specifically listed as "GOLGA6L24P") and does not encode a confirmed functional protein in humans[1][8]. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional due to mutations or lack of regulatory elements[2][4]. There are no direct links to therapeutic drug targeting, biomarker applications, or documented physiological or disease roles for GOLGA6L24 specifically. No interacting drugs, mechanisms of action, or safety considerations have been reported for this pseudogene. While some pseudogenes can have regulatory functions at the RNA level (such as acting as microRNA decoys or regulators of gene expression), there is no specific evidence for such roles for GOLGA6L24[4][6].\n\nSummary: GOLGA6L24 is a pseudogene in the human genome tied to the golgin family but is not a functional receptor, enzyme, or drug target. Its primary significance is in genomic annotation rather than therapeutic relevance[1][8].

Other names
Golgin subfamily A member 6-like protein 24GOLGA6L24golgin A6 family like 24GOLGA6L24Pgolgin subfamily A member 6-like protein 24golgin A6 family-likepseudogene
02

Biological functions

Other (no established protein-coding or direct biological function)
03

Disease associations

Other (no established disease roles or clinical associations)

Beyond the preview

Go deeper on Golgin A6 family like 24 (GOLGA6L24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgin A6 family like 24 (GOLGA6L24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call